Saniona announces outcome of warrant exercise
September 23, 2020
Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, announced today the outcome in the exercise of warrants of series TO 2, that was issued in connection with Saniona’s rights issue and directed issue in the first quarter of 2020. During the period September 7 – 21, 2020, holders of warrants of series TO 2 had the right to subscribe for new shares, by exercise of warrants. In total, 1,329,141 warrants of series TO 2 were exercised, corresponding to a subscription rate of approx. 90 percent. Saniona will thereby receive proceeds of approx. SEK 33.2 million (USD 3.6 million), before issue costs, which amount to approx. SEK 0.4 million.
Number of shares and share capital
Saniona will receive proceeds of approx. SEK 33.2 million, before issue costs. Issue costs amount to approx. SEK 0.4 million. When the new shares have been registered with the Swedish Companies Registration Office (“Bolagsverket”), the total number of shares in Saniona will amount to 62,372,831 shares and the share capital will amount to SEK 3,118,641.55.
“Saniona has had a very exciting and busy year, with an expansion in the US and a financing round that provided the company with approximately USD 65 million. As shareholders have now also exercised warrants of series TO 2, we are even better equipped and can continue to accelerate our expansion and growth journey. We are thankful for their confidence in the company's strategy going forward,” says Rami Levin, President & CEO.
Financial advisor, legal advisor, and issuing agent
Sedermera Fondkommission is financial advisor and issuing agent and Setterwalls Advokatbyrå is legal advisor to Saniona in connection with the issue and exercise of warrants.
For more information regarding the warrants of series TO 2, please contact Sedermera Fondkommission
Phone: +46 40-615 14 10, Email: email@example.com
For more information about Saniona, please contact
Trista Morrison, Chief Communications Officer. Mobile + 1 (858) 229 1738. Email: firstname.lastname@example.org
This information is such information as Saniona AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 7.00 p.m. CEST on September 23, 2020.
Saniona is a rare disease biopharmaceutical company focused on research, development and commercialization of treatments for the central nervous system. The company has four programs in clinical development. Saniona intends to develop and commercialize treatments for rare disease indications such as hypothalamic obesity and Prader-Willi syndrome on its own. The research is focused on ion channels and the company has a broad portfolio of research programs. Saniona also has out-licensing agreements with Boehringer Ingelheim GmbH, Productos Medix, S.A de S.V and Cadent Therapeutics. Saniona is based in Copenhagen, Denmark, and in Boston, US. The company’s shares are listed on Nasdaq Stockholm Small Cap (OMX: SANION). Read more at www.saniona.com.
The information in this press release does not contain or constitute an offer to acquire, subscribe or otherwise trade in shares, warrants or other securities in Saniona. An offer to the persons concerned to subscribe for units consisting of warrants in Saniona has only been made through the prospectus that Saniona published on February 14, 2020.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Skyharbour Signs Letter of Intent with Pitchblende Energy to Option 80% of the North Falcon Point Uranium Property22.10.2020 14:00:10 CEST | Press release
VANCOUVER, British Columbia, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH)(OTCQB: SYHBF) (Frankfurt:SC1P) (the “Company”) is pleased to announce the execution of a letter of intent (the “LOI”) with Australian-registered Pitchblende Energy Pty Ltd (“Pitchblende”), which provides Pitchblende an earn-in option to acquire an 80% working interest in the North Falcon Point Uranium Project, to be renamed the Hook Lake Uranium Project (the “Property”). Skyharbour’s Uranium Project Map in the Athabasca Basin: https://skyharbourltd.com/_resources/maps/SYH-Athabasca-MapOct2020.pdf Under the LOI, and subject to completion of the acquisition of Pitchblende by ASX-listed Valor Resources Limited (ASX: VAL) (“Valor”), Pitchblende will contribute cash and exploration expenditure consideration totaling CAD $3,925,000 over a three-year period (“Project Consideration”). Of the Project Consideration, $425,000 will be in cash payments to Skyharbour as well as $3,500,000 in explora
Cargotec’s interim report January–September 2020: Performance improved from the second quarter22.10.2020 13:00:00 CEST | Press release
CARGOTEC CORPORATION, Q3 2020 INTERIM REPORT, 22 OCTOBER 2020 AT 2:00 PM EEST Cargotec’s interim report January–September 2020: Performance improved from the second quarter Orders received, sales and comparable operating profit improved from Q2/2020 but remained below the comparison periodCost savings and productivity improvements enhanced profitabilityCargotec expects its comparable operating profit for H2/2020 to increase compared to H1/2020Cargotec and Konecranes announced plans to merge on 1 October. The merger is subject to the obtaining of merger control approvals, among other items. July–September 2020 in brief: Relative profitability at the comparison period’s level Orders received decreased by 14 percent and totalled EUR 740 (858) million.Order book amounted to EUR 1,751 (31 Dec 2019: 2,089) million at the end of the period.Sales decreased by 14 percent and totalled EUR 777 (901) million.Service sales decreased by 9 percent and totalled EUR 244 (269) million.Service and softwa
Cargotec's financial information in 202122.10.2020 12:50:00 CEST | Press release
CARGOTEC CORPORATION, STOCK EXCHANGE RELEASE, 22 OCTOBER 2020 AT 1:50 PM (EEST) Cargotec's financial information in 2021 Cargotec Corporation will disclose the following financial information in 2021: Financial Statements review 2020, on Thursday, 4 February 2021 Interim report January-March 2021, on Wednesday, 28 April 2021 Half year financial report January-June 2021, on Wednesday, 28 July 2021 Interim report January-September 2021, on Thursday, 28 October 2021 Cargotec's Financial Statements 2020 and Annual Report 2020 will be available at www.cargotec.com on week 8. The Annual General Meeting of Cargotec Corporation will be held on Tuesday, 23 March 2021. Shareholders, who request a certain issue belonging to the General Meeting to be included in the agenda of the Meeting, must notify the Board of Directors in writing no later than 5 January 2021 by mail: Cargotec Corporation, Board of Directors, P.O. Box 61, FI-00501 Helsinki, Finland. For further information, please contact: Hann
Correction: RESULT OF RIKSBANK REVERSED AUCTIONS SEK COVERED BONDS22.10.2020 11:31:26 CEST | Press release
RESULT OF RIKSBANK REVERSED AUCTIONS SEK COVERED BONDS Auction date2020-10-22Loan5533 Coupon1.25 %ISIN-codeSE0010442731Maturity2023-09-20 Tendered volume, SEK mln1,000 +/- 500 Volume offered, SEK mln2,000Volume bought, SEK mln1,000Number of bids3Number of accepted bids1Average yield-0.004 %Lowest accepted yield-0.004 %Highest yield-0.004 %% accepted at lowest yield 100.00 Auction date2020-10-22Loan576 Coupon1.00 %ISIN-codeSE0010049841Maturity2023-12-20 Tendered volume, SEK mln1,000 +/- 500 Volume offered, SEK mln2,500Volume bought, SEK mln1,000Number of bids7Number of accepted bids5Average yield0.021 %Lowest accepted yield0.015 %Highest yield0.026 %% accepted at lowest yield 8.00 Auction date2020-10-22Loan1587 Coupon1.50 %ISIN-codeSE0010441303Maturity2023-06-01 Tendered volume, SEK mln1,000 +/- 500 Volume offered, SEK mln2,000Volume bought, SEK mln1,000Number of bids3Number of accepted bids2Average yield-0.032 %Lowest accepted yield-0.035 %Highest yield-0.029 %% accepted at lowest yiel
Mandalay Resources Corporation meddelar de senaste borrningsresultaten för Youle-fyndigheten vid Costerfield med viktiga punkter för utvidgningen på djupet av höghaltigt guld22.10.2020 10:25:09 CEST | Pressemelding
TORONTO, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation (”Mandalay” eller ”bolaget”) (TSX: MND, OTCQB: MNDJF) är glada över att meddela om utvidgningen av höghaltigt guld till ett nytt område cirka 100 meter (”m”) under den nuvarande gruvverksamheten i Youle-fyndigheten. Viktiga punkter för Youle-borrningen De första resultaten från det nya höghaltiga guldområdet på djupet: 99,8 g/t guld och 0,2 % antimon över en sann bredd på 0,30 m i BC105;och60,3 g/t guld och 0,2 % antimon över en sann bredd på 0,24 m i BC145; och144,7 g/t guld och 0,0 % antimon över en sann bredd på 0,57 m i BC151 Fortsatt borrning norrut i Youle har gett höjdpunkter som: 84,3 g/t guld och 53,8 % antimon över en sann bredd på 0,44 m i BC116; och186,0 g/t guld och 37,4 % antimon över en sann bredd på 0,27 m i BC140; och214,0 g/t guld och 0,0% antimon över en sann bredd på 0,18 m i BC149 som är det mest djupgående hålet. OBS! En fullständig lista över viktiga kompositer vid borrning finns i tabeller
SpareBank 1 SMN: Presentation of 3rd Quarter 2020 accounts22.10.2020 10:17:52 CEST | Press release
SpareBank 1 SMN is presenting 3rd quarter 2020 financial results. Time: Friday 30 October at 08:00 AM CET Place: Webinar Please register by 28 October on the link below: http://epost.sparebank1.no/public/event/RegistrationForm/4245514073474A58427140 The presentation will be held in Norwegian by group CEO Jan-Frode Janson and CFO Kjell Fordal. We will also host a Global Investor Webinar in English on the same day at 3:15 PM CET. Please register by 28 October on the following link: http://epost.sparebank1.no/public/event/RegistrationForm/4245514076424B5F4A7740 Questions to the management in relation to both presentations can be sent to email@example.com. This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)